Cardiff Oncology Announces New Patent With Claims for Onvansertib

TipRanksNov 19 08:16 ET

Express News | Cardiff Oncology Inc: Announces New Patent With Claims for Use of Onvansertib in Treating Kras Mutated Mcrc

ReutersNov 19 08:05 ET

Here's Why We're Watching Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Situation

Simply Wall StNov 15 06:17 ET

Cardiff Oncology Reports Positive Q3 2024 Results and Clinical Progress

TipRanksNov 8 23:17 ET

Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 8 14:40 ET · Ratings

Express News | Cardiff Oncology Shares Are Trading Lower. The Company Reported Q3 Financial Results

BenzingaNov 8 12:02 ET